Browse studies

Find your next paid study

27,292 recruiting studies available now

A Phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

A phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Observation in Participants with Intermediate Risk Non-Muscle Invasive Bladder Cancer …

Intermediate Risk Non-Muscle Invasive Bladder Cancer

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Ferring PharmaceuticalsNCT06510374

Phase 2

A Phase II Randomized Trial of Adjuvant Therapy With Pembrolizumab After Resection of Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma With High Risk Features

This phase II trial studies the effect of pembrolizumab alone compared to the usual approach (chemotherapy \[cisplatin and carboplatin\] plus radiation therapy…

Recurrent Head and Neck Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+2 more

Estimated

~$75 – $1,800

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT04671667

Observational

Cognitive Enhancement in Recurrent Depression (The COG-D-R Study)

The goal of this clinical trial is to learn if a combination of non-drug treatments works to benefit memory, thinking, and brain functioning in older individua…

AgingDepressionCognitive Symptoms

Estimated

~$10 – $750

Actual pay is set by the research site.

Vanderbilt University Medical CenterNCT07527273

Phase 3

A Double-Masked, Randomized, Placebo-Controlled, Paired-Eye Study to Evaluate the Efficacy, Safety and Tolerability of Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Due to the c.2991+1655A>G (p.Cys998X) Mutation in the CEP290 Gene

The purpose of this double-masked, randomized, placebo-controlled, paired-eye study is to evaluate the efficacy, safety and tolerability of Sepofarsen in subje…

Leber Congenital Amaurosis 10BlindnessLeber Congenital Amaurosis+7 more

Estimated

~$50 – $2,250

Actual pay is set by the research site.

Laboratoires TheaNCT06891443

Observational

Differential Absorption Kinetics of Grape Seed Extract Polyphenols: A Pilot Study

Grape seed extracts (GSEs) contain (poly)phenols that vary in their degree of polymerization, which may lead to differences in absorption, metabolism, and biol…

Healthy Adults

Estimated

~$10 – $750

Actual pay is set by the research site.

Clinical Nutrition Research Center, Illinois Institute of TechnologyNCT07886385

Observational

Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium

The objective of this study is to evaluate the safety, tolerability, and preliminary efficacy of the Motif eXternally powered Cortical Stimulation (XCS) System…

Major Depressive Disorder

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Motif Neurotech, Inc.NCT07594483

Hematologic Malignancy Biology Study

This study will collect tumor samples from people with cancers of the blood, bone marrow, or lymph glands for laboratory study of the biology of these conditio…

Acute Lymphoblastic LeukemiaMyelodysplastic Syndrome (MDS)Non-Hodgkins Lymphoma+2 more

Estimated

~$10 – $675

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT00923442

Phase 3

An Extension Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig, Including Inhaled Corticosteroid Withdrawal, in Adults With Chronic Obstructive Pulmonary Disease (COPD) Who Completed Studies EFC18243 or EFC18244

This is an open-label, Phase 3, long-term safety extension study including participants of previous lunsekimig clinical trials with inadequately controlled chr…

Chronic Obstructive Pulmonary Disease

Estimated

~$50 – $2,250

Actual pay is set by the research site.

SanofiNCT07793409

Observational

Multi-Level Interventions to Reduce Oral Health Disparities Among Adults in Primary Care Settings

This study is a Stage III cRCT to test the efficacy of multi-level interventions at the practice- and provider-level to address low dental utilization (attenda…

Dental CariesDry MouthPeriodontal Diseases+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Case Western Reserve UniversityNCT06555029

Phase 2

Larotrectinib to Enhance RAI Avidity in Patients With Differentiated Thyroid Cancer Harboring NTRK Fusions (LANTERN)

Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced …

Differentiated Thyroid CancerPediatric CancerCancer+1 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Children's Hospital of PhiladelphiaNCT05783323

Observational

Feasibility of a Community-Based Cancer Survivor Exercise and Nutrition Education Program: Effects on Self-Efficacy, Quality of Life and Functional Performance

This clinical trial evaluates whether a supervised community-based exercise and nutrition program is usable and effective for improving cancer survivors' confi…

Hematopoietic and Lymphatic System NeoplasmMalignant Solid Neoplasm

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Roswell Park Cancer InstituteNCT06565260

Phase 1

An Open Label, First-in-human Study of BAY 2927088 in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) Harboring an EGFR and/or HER2 Mutation

Researchers are looking for a better way to treat people who have advanced non-small cell lung cancer (NSCLC), a group of lung cancers that have spread to near…

Advanced Non-small Cell Lung CancerEGFR MutationHER2 Mutation

Estimated

~$150 – $4,500

Actual pay is set by the research site.

BayerNCT05099172